Celltrion has announced groundbreaking results from a two-year study on dose escalation of subcutaneous infliximab (CT-P13 SC ...

The Scottish Medicines Consortium (SMC) has recommended MSD’s KEYTRUDA (pembrolizumab) as a monotherapy for adults with ...

Sanofi has announced the launch of its high-dose egg-based quadrivalent influenza vaccine (QIV-HD) in the UK. This vaccine is ...

This decision aligns with the recent approval by Scotland’s SMC to use teclistamab on the NHS. Teclistamab, a bispecific ...

Copenhagen-based biotech company FluoGuide A/S has announced the submission of a Clinical Trial Application (CTA) for a phase ...

IRLAB Therapeutics AB has announced the successful completion of the first part of its Phase I clinical trial for IRL757, a ...

Purespring Therapeutics has raised £80m in an oversubscribed Series B financing round. Syncona Ltd, a leading life science ...

In a landmark study, Johnson & Johnson has announced that ERLEADA (apalutamide) significantly reduces the risk of death by 23 ...

Cardiologists at Sheffield Teaching Hospitals NHS Foundation Trust have performed a cutting-edge heart valve replacement procedure live to an international audience. The streamlined transcatheter ...

Cancer Grand Challenges, a pioneering initiative co-founded by Cancer Research UK and the US National Cancer Institute (NCI), has launched a global search to identify the most pressing challenges in ...